| 2.1 Safe use of antithrombotics for stroke prevention in atrial fibrillation: considerations of risk assessment tools to support decision-making Y Wang, BV Bajorek Therapeutic Decision-making around Stroke Prevention in Atrial Fibrillation, 21, 2016 | | 2016 |
| 3.1 Clinical pre-test of a Computerised Antithrombotic Risk Assessment Tool for stroke prevention in atrial fibrillation patients: giving consideration to NOACs Y Wang, BV Bajorek Therapeutic Decision-making around Stroke Prevention in Atrial Fibrillation, 100, 2016 | | 2016 |
| 354 UTILIZATION OF EVIDENCE-BASED DRUG THERAPIES FOR THE SECONDARY PREVENTION OF STROKE IN AUSTRALIAN PRACTICE A Eissa, I Krass, B Bajorek Journal of Hypertension 30, e104, 2012 | | 2012 |
| 4.1 Selecting antithrombotic therapy for stroke prevention in atrial fibrillation (AF): health professionals’ feedback on a decision support tool Y Wang, BV Bajorek Therapeutic Decision-making around Stroke Prevention in Atrial Fibrillation, 128, 2016 | | 2016 |
| 6.1 Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2. 0) for stroke prevention in atrial fibrillation Y Wang, BV Bajorek Therapeutic Decision-making around Stroke Prevention in Atrial Fibrillation, 187, 2016 | | 2016 |
| 7.1 Old age, high risk medication, polypharmacy—a ‘trilogy’of risks associated with medication use in the elderly with atrial fibrillation. Y Wang, S Singh, B Bajorek Therapeutic Decision-making around Stroke Prevention in Atrial Fibrillation, 218, 2016 | | 2016 |
| 7.2 Stroke prevention in atrial fibrillation: impact of a Computerised Risk Assessment Tool (CARAT) on the prescription of thromboprophylaxis in the hospital setting. EY Pandya, N Mansood, Y Wang, I Krass, B Bajorek Therapeutic Decision-making around Stroke Prevention in Atrial Fibrillation, 248, 2016 | | 2016 |
| A cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool to optimize stroke prevention in general practice: a study protocol B Bajorek, P Magin, S Hilmer, I Krass BMC Health Services Research 14, 1-9, 2014 | 21 | 2014 |
| A community pharmacy based anticoagulant management service A McLachlan, M Spindler, R Fois, I Krass, T Chen, B Bajorek Canberra: The Pharmacy Guild of Australia, 2002 | 7 | 2002 |
| A global perspective of the roles of the pharmacist in the NICU N Krzyzaniak, B Bajorek International Journal of Pharmacy Practice 25 (2), 107-120, 2017 | 31 | 2017 |
| A participatory research approach in community pharmacy research: The case for video-reflexive ethnography FR Yong, SY Hor, BV Bajorek Research in Social and Administrative Pharmacy 18 (1), 2157-2163, 2022 | 4 | 2022 |
| A qualitative analysis of warfarin management after discharge from hospital L Chalmers, I DeBoos, G Peterson, B Bajorek, S Jackson, L Bereznicki University of Tasmania, 2010 | | 2010 |
| A qualitative analysis of warfarin management after discharge from hospital L Stafford, I DeBoos, GM Peterson, B Bajorek, SL Jackson, ... Pharmacy Practice Research Summit 2010, 18, 2010 | | 2010 |
| A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks B Bajorek Therapeutic advances in drug safety 2 (2), 45-58, 2011 | 45 | 2011 |
| A survey of long‐term antiarrhythmic therapy in elderly patients with atrial fibrillation BV Bajorek, I Krass, SJ Ogle, MJ Duguid, GM Shenfield The Australian Journal of Hospital Pharmacy 31 (2), 93-97, 2001 | 3 | 2001 |
| A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting TM Alhawassi, I Krass, BV Bajorek, LG Pont Clinical interventions in aging, 2079-2086, 2014 | 388 | 2014 |
| Access to medicines for hypertension: a survey in rural Yogyakarta province, Indonesia R Rahmawati, BV Bajorek Rural and Remote Health 18 (3), 1-13, 2018 | 23 | 2018 |
| Acknowledgement of external reviewers L Aagaard, D Abdel-Qader, S AbuRuz, AM Advinha, ZMI Ahmed, ... Int J Clin Pharm 36, 213-215, 2014 | | 2014 |
| Addressing multimorbidity and polypharmacy in individuals with atrial fibrillation F Shaikh, LB Pasch, PJ Newton, BV Bajorek, C Ferguson Current cardiology reports 20, 1-12, 2018 | 32 | 2018 |
| Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population M Alene, MD Wiese, MT Angamo, BV Bajorek, EA Yesuf, NT Wabe BMC clinical pharmacology 12, 1-9, 2012 | 52 | 2012 |
